| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
173,970,000 |
| Market
Cap: |
4.80(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.54 - $43.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,500 |
115,745 |
1,769,632 |
2,886,602 |
| Total Sell Value |
$85,000 |
$4,770,514 |
$61,715,300 |
$73,415,196 |
| Total People Sold |
1 |
3 |
6 |
6 |
| Total Sell Transactions |
1 |
7 |
14 |
29 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Henderson Michael Thomas |
See Remarks |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
173,767 |
173,767 |
|
- |
|
| Homcy Charles J |
Chairman of Pharmaceuticals |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,361,426 |
1,361,426 |
|
- |
|
| Mccormick Frank |
Chairman of Oncology |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,361,426 |
1,361,426 |
|
- |
|
| Kkr Genetic Disorder Gp Llc |
10% Owner |
– – • |
2019-07-01 |
4 |
B |
$17.00 |
$45,000,700 |
I/I |
2,647,100 |
36,900,661 |
1.5 |
- |
|
| Kkr Genetic Disorder Gp Llc |
10% Owner |
– – • |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
34,253,561 |
34,253,561 |
|
- |
|
| Scheller Richard H |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
163,427 |
163,427 |
|
- |
|
| Kumar Neil |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,328,061 |
927,686 |
|
- |
|
| Kumar Neil |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,624,367 |
7,624,367 |
|
- |
|
| Stephenson Brian C |
See Remark |
• – – |
2019-07-01 |
4 |
B |
$17.00 |
$943,500 |
D/D |
55,500 |
368,446 |
2.74 |
- |
|
| Stephenson Brian C |
See Remark |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
312,946 |
312,946 |
|
- |
|
| Turtle Cameron |
See Remarks |
• – – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,630 |
12,630 |
|
- |
|
| Shabet Rose Sharon |
10% Owner |
– – • |
2019-06-27 |
4 |
B |
$17.00 |
$80,000,300 |
I/I |
4,705,900 |
26,620,991 |
1.5 |
- |
|
| Shabet Rose Sharon |
10% Owner |
– – • |
2019-06-27 |
4 |
A |
$0.00 |
$0 |
I/I |
21,915,091 |
21,915,091 |
|
- |
|
288 Records found
|
|
Page 12 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.21 (0.75%) 
